Jeffrey S. Heier

CIK: 0001653082

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)10 (83.3%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (16.7%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

OCUL

OCULAR THERAPEUTIX, INC

Officer

Discretionary Trading P&L

Holdings

Transaction History (12 total)

OCUL
OCULAR THERAPEUTIX, INC
Oct 2, 2026
Sale(S)
Direct
10.9K shares at avg. $7.05$77K
OCUL
OCULAR THERAPEUTIX, INC
Aug 24, 2026
Sale(S)
Direct
3.3K shares at avg. $10.78$36K
OCUL
OCULAR THERAPEUTIX, INC
May 26, 2026
Sale(S)
Direct
3K shares at avg. $8.20$25K
OCUL
OCULAR THERAPEUTIX, INC
Feb 23, 2026
Sale(S)
Direct
3.1K shares at avg. $8.28$25K
OCUL
OCULAR THERAPEUTIX, INC
Jan 2, 2026
Award(A)
Direct
79.1K shares-
OCUL
OCULAR THERAPEUTIX, INC
Nov 24, 2025
Sale(S)
Direct
3.5K shares at avg. $12.04$42K
OCUL
OCULAR THERAPEUTIX, INC
Oct 2, 2025
Sale(S)
Direct
10.5K shares at avg. $11.04$116K
OCUL
OCULAR THERAPEUTIX, INC
Aug 25, 2025
Sale(S)
Direct
3.1K shares at avg. $12.04$37K
OCUL
OCULAR THERAPEUTIX, INC
May 23, 2025
Sale(S)
Direct
3K shares at avg. $7.18$22K
OCUL
OCULAR THERAPEUTIX, INC
Feb 24, 2025
Sale(S)
Direct
3.1K shares at avg. $6.87$21K
OCUL
OCULAR THERAPEUTIX, INC
Nov 25, 2024
Sale(S)
Direct
2.9K shares at avg. $9.01$27K
OCUL
OCULAR THERAPEUTIX, INC
Oct 2, 2024
Award(A)
Direct
100K shares-

		Type	Shares	Price		Ownership
Oct 2, 2026	OCUL OCULAR THERAPEUTIX, INC	Sale(S)	10,869	$7.05	$76,626	Direct
Aug 24, 2026	OCUL OCULAR THERAPEUTIX, INC	Sale(S)	3,296	$10.78	$35,531	Direct
May 26, 2026	OCUL OCULAR THERAPEUTIX, INC	Sale(S)	3,018	$8.20	$24,748	Direct
Feb 23, 2026	OCUL OCULAR THERAPEUTIX, INC	Sale(S)	3,057	$8.28	$25,312	Direct
Jan 2, 2026	OCUL OCULAR THERAPEUTIX, INC	Award(A)	79,112	-	$0	Direct
Nov 24, 2025	OCUL OCULAR THERAPEUTIX, INC	Sale(S)	3,469	$12.04	$41,767	Direct
Oct 2, 2025	OCUL OCULAR THERAPEUTIX, INC	Sale(S)	10,502	$11.04	$115,942	Direct
Aug 25, 2025	OCUL OCULAR THERAPEUTIX, INC	Sale(S)	3,063	$12.04	$36,879	Direct
May 23, 2025	OCUL OCULAR THERAPEUTIX, INC	Sale(S)	3,024	$7.18	$21,712	Direct
Feb 24, 2025	OCUL OCULAR THERAPEUTIX, INC	Sale(S)	3,061	$6.87	$21,029	Direct
Nov 25, 2024	OCUL OCULAR THERAPEUTIX, INC	Sale(S)	2,948	$9.01	$26,561	Direct
Oct 2, 2024	OCUL OCULAR THERAPEUTIX, INC	Award(A)	100,000	-	$0	Direct

1-12 of 12 transactions

About Heier Jeffrey S.

Heier Jeffrey S. (SEC CIK 0001653082) files insider reports with the SEC as Chief Scientific Officer of OCULAR THERAPEUTIX, INC (OCUL).

Signal8 holds 13 ownership filings by Heier Jeffrey S. (1 Form 3, 12 Form 4), filed between Oct 4, 2024 and Oct 6, 2026. Those filings report 12 transactions, from Oct 2, 2024 to Oct 2, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Heier Jeffrey S.'s filings is in BEDFORD, MA.

Recent filings by Heier Jeffrey S.

Oct 2, 2026: Open-market sale of OCUL shares (Form 4, code S).
Aug 24, 2026: Open-market sale of OCUL shares (Form 4, code S).
May 26, 2026: Open-market sale of OCUL shares (Form 4, code S).
Feb 23, 2026: Open-market sale of OCUL shares (Form 4, code S).
Jan 2, 2026: Grant or award of OCUL shares (Form 4, code A).

Other insiders filing for OCULAR THERAPEUTIX, INC (OCUL)

Anderman Todd, Chief Legal Officer
Kaiser Peter, Chief Development Officer
Notman Donald, Chief Operating Officer
Nayak Sanjay, Chief Strategy Officer
Dugel Pravin
Warden Charles M, Director

How to read Form 4 transaction codes